548472-48-6 Usage
Uses
Used in Organic Synthesis:
Ethyl 2-isopropoxy-4-methoxybenzimidate hydrochloride is used as a reagent in organic synthesis for the preparation of various pharmaceutical and agricultural chemicals. Its unique structure and reactivity make it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Ethyl 2-isopropoxy-4-methoxybenzimidate hydrochloride is used as a building block in the synthesis of novel heterocyclic compounds. These heterocyclic compounds have potential applications as new drugs and therapeutic agents, contributing to the development of innovative treatments for various diseases.
Used in Drug Development:
Ethyl 2-isopropoxy-4-methoxybenzimidate hydrochloride has potential applications in the development of new drugs and therapeutic agents. Its unique chemical properties and reactivity make it a promising candidate for the creation of novel pharmaceutical compounds with improved efficacy and selectivity.
Used in Agricultural Chemicals:
Ethyl 2-isopropoxy-4-methoxybenzimidate hydrochloride is also used in the preparation of agricultural chemicals, such as pesticides and herbicides. Its role in these applications is to provide a stable and effective active ingredient that can help control pests and weeds in agricultural settings.
Check Digit Verification of cas no
The CAS Registry Mumber 548472-48-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,8,4,7 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 548472-48:
(8*5)+(7*4)+(6*8)+(5*4)+(4*7)+(3*2)+(2*4)+(1*8)=186
186 % 10 = 6
So 548472-48-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H19NO3.ClH/c1-5-16-13(14)11-7-6-10(15-4)8-12(11)17-9(2)3;/h6-9,14H,5H2,1-4H3;1H
548472-48-6Relevant academic research and scientific papers
Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
-
Page/Page column 13, (2010/04/23)
The invention relates to dihydroimidazoles of formula rac-(I), wherein the radicals and symbols are as defined herein; their use as inhibitors of the interaction of the MDM2 protein with a p53-like peptide, new pharmaceutical formulations comprising said compounds, said compounds for use in the therapeutic treatment of warm-blooded animals, especially humans, their use in the treatment of proliferative diseases or for the manufacture of pharmaceutical formulations useful in the treatment of proliferative diseases that respond to modulation of the interaction of the MDM2 protein with a p53-like peptide, a pharmaceutical formulation e.g. useful in the treatment of proliferative diseases that respond to modulation of the interaction of the MDM2 protein with a p53-like peptide comprising said compound, methods of treatment comprising administration of said compounds to a warm-blooded animal, and/or processes for the manufacture of said compounds.
Cis-imidazolines
-
, (2008/06/13)
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and
Cis-imidazolines
-
, (2008/06/13)
The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity
